Vertex seeking $375M note deal

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) proposed late Wednesday to raise $375 million in an offering of convertible senior subordinated notes due 2015. BofA Merrill Lynch is underwriter for the offering. Vertex was off $0.05 to $36.17 on Wednesday. ...